For the Inventor, By the Inventor

Enter assignee name

Hamilton, MT, United States of America

Ribi Immunochem Research, Inc.

USPTO Granted Patents = 25

Forward Citations = 1,147

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

John L Cantrell (12 out of 12 patents)

Edgar E Ribi (10 out of 10 patents)

Steven M Schwartzman (4 out of 4 patents)

4. Gary Elliott (2 out of 30 patents)

5. C Gregory Sowell (2 out of 33 patents)

6. Kent Raymond Myers (2 out of 7 patents)

7. David A Johnson (1 out of 35 patents)

8. J Terry Ulrich (1 out of 4 patents)

9. Glen D Leesman (1 out of 7 patents)

10. Patricia A Weber (1 out of 3 patents)

11. Alex T Truchot (1 out of 1 patent)

12. Edgar F Ribi, Deceased (1 out of 1 patent)

13. Jean S Marshall (1 out of 1 patent)

14. Jerry Dolovich (1 out of 1 patent)

15. Cantrell John L (1 out of 1 patent)

Core Competencies:

Adjuvant Composition

Monophosphoryl Lipid A

Detoxified Endotoxin

Vaccine Adjuvants

Ischemia Treatment

Hypersensitivity Treatment

Polysaccharide Vaccines

Immunological Emulsions

Pyridine-Soluble Extracts

Tissue Damage Amelioration

Septicemia Inhibition

Radiation Syndrome

25 patents: Sort by Forward Citations

1. 6630161 - Adjuvant composition and methods for its use (2003-10-07),

2. 6113918 - Aminoalkyl glucosamine phosphate compounds and their use as adjuvants (2000-09-05),

3. 6013640 - Phosphoglycolipid and methods for its use (2000-01-11),

4. 5762943 - Methods of treating type I hypersensitivity using monophosphoryl lipid A (1998-06-09),

5. 5286718 - Method and composition for ameliorating tissue damage due to ischemia (1994-02-15),

6. 4987237 - Derivatives of monophosphoryl lipid A (1991-01-22),

7. 4912094 - Modified lipopolysaccharides and process of preparation (1990-03-27),

8. 4877611 - Vaccine containing tumor antigens and adjuvants (1989-10-31),

9. 4866034 - Refined detoxified endotoxin (1989-09-12),

10. 4844894 - Method of inhibiting the onset of septicemia and endotoxemia (1989-07-04),

11. 4806352 - Immunological lipid emulsion adjuvant (1989-02-21),

12. 4803070 - Immunological emulsion adjuvants for polysaccharide vaccines (1989-02-07),

13. 4663306 - Pyridine-soluble extract-refined detoxified endotoxin composition and use (1987-05-05),

14. 4629722 - Method of inhibiting the onset of acute radiation syndrome (1986-12-16),

15. 4613504 - Pyridine-soluble extracts of microorganisms (1986-09-23),

Ribi Immunochem Research, Inc. is a biotechnology company based in Hamilton, Montana, specializing in the development and manufacturing of immunological products. The organization focuses on creating innovative solutions for the diagnosis and treatment of various diseases, leveraging advanced research in immunochemistry. Ribi's expertise encompasses a range of applications, including vaccine development and therapeutic agents, aimed at enhancing health outcomes through targeted immunological interventions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

25 Patents

#1 in Hamilton, MT

#9 in Montana

#13,350 in US

#25,681 in the World

Hamilton, MT, United States of America

Ribi Immunochem Research, Inc.

Forward Citations = 1,147

16 inventors:

John L Cantrell (12 out of 12 patents)

Edgar E Ribi (10 out of 10 patents)

Steven M Schwartzman (4 out of 4 patents)

4. Gary Elliott (2 out of 30 patents)

5. C Gregory Sowell (2 out of 33 patents)

Please report any incorrect information to [email protected]

Loading…